LFMD

LifeMD Inc

LFMD, USA

LifeMD, Inc. operates as a direct-to-patient telehealth company that connects consumers to healthcare professionals for medical care in the United States. The company operates through two operating segments: Telehealth and WorkSimpli. The company offers telehealth platform comprising RexMD, a men's telehealth brand that provides access to virtual medical treatment for a variety of men's health needs, including erectile dysfunction, premature ejaculation, and hair loss; ShapiroMD that provides virtual medical treatment, prescription medications, patented doctor formulated OTC products, topical compounded medications, and medical devices treating male and female hair loss; and Cleared which provides personalized treatments for allergy, asthma and immunology. It also provides LifeMD PC, a virtual primary care and telehealth service which is a provider for their primary care, urgent care, and chronic care needs; and offers virtual medical care, including on-demand consultations and treatment, prescription medications, diagnostics and imaging, wellness coaching, integration with in-home tools, and more. In addition, the company offers PDFSimpli, an online software as a service platform that allows users to create, edit, convert, sign, and share PDF documents; ResumeBuild which provides digital resume and cover letter services; SignSimpli, a digital signature platform; and LegalSimpli, a provider of legal forms for consumers and small businesses. Further, it offers GLP-1 for weight management and in-home health monitoring devices. It sells its products directly to consumers and through e-commerce platforms, as well as through third party partner channels. The company was formerly known as Conversion Labs, Inc. and changed its name to LifeMD, Inc. in February 2021. LifeMD, Inc. was incorporated in 1994 and is headquartered in New York, New York.

https://lifemd.com

Stock Price

$ 0.00

0% decrease compared to yesterday.

Dividend

Frequency:

N/A

Rate:

N/A

Next Payout:

N/A
LFMD
stock
LFMD

Insider Selling: LifeMD (NASDAQ:LFMD) CMO Sells 15,000 Shares of Stock MarketBeat

Read more →
LFMD
stock
LFMD

LifeMD Executive Makes a Bold Move with Stock Sale TipRanks

Read more →

Showing 2 of 10

Analyst Ratings & Sentiment

(Last Updated 2025-09-30)

Rating:

STRONG BUY

Target Price:

$9.25

Analyst Picks

Strong Buy

6

Buy

1

Hold

1

Sell

0

Strong Sell

0

Sentiment:

Bullish

Finn Analysis

(Last Updated 2025-09-30)

Health Score

Price to Book Ratio (P/B)

-

Very High

120.29

Low ≤ 1

High ≥ 3

Return on Equity (ROE)

-

Very Low

-289.59 %

Low ≤ 5%

High ≥ 25%

Return on Assets (ROA)

-

Very Low

-5.77 %

Low ≤ 2%

High ≥ 10%

Free Cash Flow - Revenue % (FCF)

-

Very Low

-11.16 %

Low ≤ 5%

High ≥ 15%

Debt to Equity

-

Very Low

47.64

Low ≥ 1

High ≤ 0.3

Investors

* Institutions hold a combined 52.24% of the total shares of LifeMD Inc

1.

BlackRock Inc

(5.5996%)

since

2025/06/30

2.

Vanguard Group Inc

(4.3995%)

since

2025/06/30

3.

Morgan Stanley - Brokerage Accounts

(3.3601%)

since

2025/06/30

4.

D. E. Shaw & Co LP

(2.5725%)

since

2025/06/30

5.

Nuveen, LLC

(2.4598%)

since

2025/06/30

6.

State Street Corp

(2.4%)

since

2025/06/30

7.

Renaissance Technologies Corp

(2.2907%)

since

2025/06/30

8.

Vanguard Total Stock Mkt Idx Inv

(2.1138%)

since

2025/07/31

9.

UBS Group AG

(1.9768%)

since

2025/06/30

10.

Connor Clark & Lunn Inv Mgmt Ltd

(1.9522%)

since

2025/06/30

11.

Geode Capital Management, LLC

(1.9511%)

since

2025/06/30

12.

iShares Russell 2000 ETF

(1.9062%)

since

2025/08/31

13.

Royce & Associates, LP

(1.6248%)

since

2025/06/30

14.

Nuveen Quant Small Cap Equity R6

(1.4183%)

since

2025/07/31

15.

Jump Financial LLC

(1.0862%)

since

2025/06/30

16.

Two Sigma Investments LLC

(0.9501%)

since

2025/06/30

17.

Arrowstreet Capital Limited Partnership

(0.9173%)

since

2025/06/30

18.

Vanguard Institutional Extnd Mkt Idx Tr

(0.9042%)

since

2025/07/31

19.

Royce Small-Cap Opportunity Invmt

(0.878%)

since

2025/06/30

20.

JPMorgan Chase & Co

(0.8701%)

since

2025/06/30

22.

Northern Trust Corp

(0.7932%)

since

2025/06/30

23.

Fidelity Small Cap Index

(0.7788%)

since

2025/06/30

24.

Jane Street Group LLC

(0.7245%)

since

2025/06/30

25.

FTGF RY US SmCp Opp A USD Dis(A)

(0.7233%)

since

2025/08/31

27.

Amvescap Plc.

(0.6898%)

since

2025/06/30

28.

Qube Research & Technologies

(0.6524%)

since

2025/06/30

29.

Nuveen Quant Small/Mid Cap Eq R6

(0.5646%)

since

2025/07/31

30.

CREF Stock R3

(0.5597%)

since

2025/07/31

31.

iShares Russell 2000 Growth ETF

(0.4774%)

since

2025/08/31

32.

Fidelity Extended Market Index

(0.4489%)

since

2025/07/31

33.

Calamos Timpani Small Cap Growth I

(0.4245%)

since

2025/07/31

34.

Timpani Small Cap Growth Equity

(0.4141%)

since

2025/06/30

35.

Janus Henderson Small/Md Cp Gr Alpha ETF

(0.3833%)

since

2025/08/29

36.

Invesco Dorsey Wright SmallCap Momt ETF

(0.3768%)

since

2025/08/29

37.

Vanguard Russell 2000 ETF

(0.3698%)

since

2025/07/31

38.

State St Russell Sm Cap® Indx SL Cl I

(0.2533%)

since

2025/08/31

39.

Invesco Dorsey Wright Healthcare MomtETF

(0.2413%)

since

2025/08/29

40.

iShares Russell 2000 Value ETF

(0.2006%)

since

2025/08/31

* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.

Earnings History

EPS ActualEPS EstimateEPS DifferenceSurprise Percent

Upcoming Earnings Release

Date

—

EPS Estimate

—

Latest Release

Date

2025-09-30

EPS Actual

-0.0833

EPS Estimate

-0.0357

EPS Difference

-0.0476

Surprise Percent

-133.3333%

Investing Fit Scorecard

(Last Updated 2025-09-30)

Deep Value
Weak Deep Value(2)
Defensive
Moderately Defensive(5)
Dividend
Weak Dividend Profile(1)
Economic Moat
Some Competitive Advantage(3.3)
GARP
Not Attractive for GARP(1)
Growth
Weak Growth Prospect(1)
Momentum
Moderate Momentum(5)
Net Net
Not Undervalued (Net-Net)(2)
Quality
Low Quality Business(1)
Value
Overpriced(1.5)

Income Statement

(Last Updated 2025-09-30)

Revenue

$ 0

Cost Of Revenue

$ 0

Gross Profit

$ 0

Operating Expenses

$ 0

Operating Income

$ 0

Interest Expense

$ 0

Pretax Income

$ 0

Net Income

$ 0

Income Tax Expense

$ 0

EBITDA

$ 0

Total Other Income Expense Net

$ 0

Earnings Per Share

0

Dividends Per Share

0

Shares Outstanding

0

Operating Margin

0%

Trend

Balance Sheet

(Last Updated 2025-09-30)

Cash

$ 0

Short Term Investments

$ 0

Receivables

$ 0

Inventories

$ 0

Total Current Assets

$ 0

Property Plant Equipment

$ 0

Total Assets

$ 0

Payables

$ 0

Short Term Debt

$ 0

Long Term Debt

$ 0

Total Liabilities

$ 0

Equity

$ 0

Trend

Cash Flow

(Last Updated 2025-09-30)

Net Income

$ 0

Depreciation

$ 0

Change In Working Capital

$ 0

Cash From Operations

$ 0

Capital Expenditures

$ 0

Cash From Investing

$ 0

Cash From Financing

$ 0

Net Change In Cash

$ 0

Trend

Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.